Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  HIV Infection

  Free Subscription


Articles published in J Clin Oncol

Retrieve available abstracts of 6 articles:
HTML format



Single Articles


    June 2022
  1. VALANPARAMBIL RM, Carlisle J, Linderman SL, Akthar A, et al
    Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron Variant.
    J Clin Oncol. 2022 Jun 27:JCO2102986. doi: 10.1200/JCO.21.02986.
    PubMed     Abstract available


  2. ENG C, Ciombor KK, Cho M, Dorth JA, et al
    Anal Cancer: Emerging Standards in a Rare Rare Disease.
    J Clin Oncol. 2022 Jun 1:JCO2102566. doi: 10.1200/JCO.21.02566.
    PubMed     Abstract available


    March 2022
  3. RINER AN, Girma S, Vudatha V, Mukhopadhyay N, et al
    Eligibility Criteria Perpetuate Disparities in Enrollment and Participation of Black Patients in Pancreatic Cancer Clinical Trials.
    J Clin Oncol. 2022 Mar 22:JCO2102492. doi: 10.1200/JCO.21.02492.
    PubMed     Abstract available


    January 2022
  4. LOUARN N, Galicier L, Bertinchamp R, Lussato D, et al
    First Extensive Analysis of (18)F-Labeled Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in a Large Cohort of Patients With HIV-Associated Hodgkin Lymphoma: Baseline Total Metabolic Tumor Volume Affects Prognosis.
    J Clin Oncol. 2022 Jan 24:JCO2101228. doi: 10.1200/JCO.21.01228.
    PubMed     Abstract available


    December 2021
  5. RAMASWAMI R, Lurain K, Yarchoan R
    Oncologic Treatment of HIV-Associated Kaposi Sarcoma 40 Years on.
    J Clin Oncol. 2021 Dec 10:JCO2102040. doi: 10.1200/JCO.21.02040.
    PubMed     Abstract available


    January 2021
  6. OLSZEWSKI AJ, Jakobsen LH, Collins GP, Cwynarski K, et al
    Burkitt Lymphoma International Prognostic Index.
    J Clin Oncol. 2021 Jan 27:JCO2003288. doi: 10.1200/JCO.20.03288.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: